Amoeba is focused on developing and commercializing green biocide water treatment chemicals. It offers BIOMEBA, a green biocide that harnesses the biocidal properties of Willaertia magna to treat the bacterial risks encountered in cooling towers.

Shanghai Shuoying Biotechnology Co., Ltd., established on 2018-09-19, The scope of business includes engaging in technology development in the professional field of biotechnology,technology transfer,technical consulting,Technical Services,Daily necessities,biological reagent,Instrumentation,Consumables,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals)promotion of. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

CJ CheilJedang is a core subsidiary in charge of the food and bioengineering business Unit of the CJ Group. It has led the development of the Korean food industry for the past 60 years, and contributed to the development of the bioengineering industry as the nation’s top food originated company. After being launched in 1953 as a food ingredient company, continuously extended its business to processed foods. In 2007, CJ CheilJedang divided out as a subsidiary company to concentrate on the food and bioengineering business.

Mobidiag is a commercial stage, fast-growing Finnish-French biotechnology company that develops and markets innovative molecular diagnostic solutions for gastrointestinal infections, antimicrobial resistance management, healthcare associated infections (HAIs), respiratory infections and sepsis. Based on well-established qPCR and microarray technologies, Mobidiag offers a broad range of tests and automated platforms. These include a comprehensive range of fast, reliable and cost-effective molecular diagnostic solutions for the detection of infectious diseases adapted to laboratories of all sizes. They allow detection of most clinically relevant bacteria, parasites, viruses and markers for antibiotic resistance.

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.

Ningbo Sunshine Biotechnology Co., Ltd., established on 2012-05-21, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Biochemical product technology research and development;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Specialty Chemicals Sales(Free of Hazardous Chemicals);Pharmaceutical special equipment manufacturing;Sales of Class I Medical Devices;Disinfectant sales(Free of Hazardous Chemicals);Livestock Machinery Sales;Sales of daily chemical products;Import and export;Technology Import and Export;Import and export agency(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Veterinary drug production;Veterinary drug business;poultry farming(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Unilever Plc engages in the manufacture and sale of consumer goods. It operates through the following segments: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. The Beauty & Wellbeing segment offers hair care, skin care, and prestige beauty and health & wellbeing. The Personal Care segment consists of sales of skin cleansing, deodorant, and oral care products. The Home Care segment comprises of sales of fabric care and a wide range of cleaning products. The Nutrition segment refers to sales of scratch cooking aids, dressings, and tea products. The Ice Cream segment covers primarily ice cream products. The company was founded by Antonius Johannes Jurgens, Samuel van den Bergh, and William Hulme Lever on January 1, 1930 and is headquartered in London, the United Kingdom.

Part of Kitasato University, The Kitasato Institute is a company headquartered in Tokyo, Japan, that operates a research institution.

Chongqing Xinshida Biotechnology Co., Ltd., established on 2016-04-15, Business scope includes technology research and development in the field of biotechnology,transfer,consultation service;to plant,Sales:Nourishing Chinese herbal medicines;research and development,Production,Sales:Pharmaceutical Intermediates(In addition to drugs);Ecological Agriculture Development;Ecotourism;Goods and technology import and export business(Except for national prohibitions and restrictions).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)***

Green + Joint Stock Corp. engages in the manufacture and distribution of pharmaceutical and herbal products. The company was founded in 2016 and is headquartered in Ben Tre, Vietnam.

Institut de Recherche pour le Développement operates as a scientific and technical public institution which provides information, expertise, support and training in production performance. It performs research centered on the relationship between human beings and its environment in intertropical areas. In that context the IRD implements research projects on sleeping sickness and the vectors transmitting the disease. The company is headquartered in Marseille, France.

White Dog Labs, Inc. is an American private company that develops probiotics for animals and humans.\nThe company says this about itself: WDL is a biotech company focused on animal health and nutrition today – human’s tomorrow. It was established in 2012 to address global challenges including food sustainability and climate change, and is funded by Musea Ventures, the investment arm of the Somekh family. The company has a unique, world class expertise in microbiome derived organisms which have promising implications for nutrition and health. The company has invented a proprietary process, ProtocolB™, for the isolation, selection and cultivation of microbiome-derived organisms, and developed MixoFerm™, a fermentation technology that consumes sugar and gases, thus increasing product yield in industrial fermentation. WDL is applying this expertise to develop and commercialize the \"Tyton\" platform of unique products.

Otsuka Pharmaceutical Factory, Inc. manufactures and distributes pharmaceutical and nutritional products. Its products include medical foods, hine E-gel, processlead, engelead, innerpower, oronine h ointment, urepearl plus lotion 10 and urepearl plus cream. The company was founded on September 1, 1921 and is headquartered in Naruto, Japan.

Morvus Technology Ltd., a pharmaceutical company, engages in the discovery, development, and commercialization of drugs and technologies in the oncology field. Its clinical candidates include MTL-005, a therapy for cancers treated with conventional radiotherapy; MTL-007, a novel anti-cancer prodrug; and MTL-003, an anti-angiogenic cancer therapy. The company's research portfolio comprises MorTar platform technology that identifies new proteins and genes that share the ability to inhibit apoptosis; HAI-X, an anti-angiogenic treatment for prostate cancer; and MorGen, a novel prodrug-activating system. The company also engages in the development of anti-cancer treatments using genetic modification techniques. In addition, it offers MorAnt, an anti-parasitic drug; and MorRid, a rodenticide. Morvus Technology Ltd. was founded in 2004 and is based in Carmarthen, the United Kingdom.

The American Can Company was a manufacturer of tin cans. It was a member of the Tin Can Trust, that controlled a "large percentage of business in the United States in tin cans, containers, and packages of tin." American Can Company ranked 97th among United States corporations in the value of World War II military production contracts. It was formerly a member of the Dow Jones Industrial Average from 1959–1991, though after 1987 it had renamed itself Primerica, a financial conglomerate which had divested itself of its packaging arm in 1986.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Biotest Pharma GmbH engages in the manufacture and distribution of medicinal and pharmaceutical products. The company is headquartered in Dreieich, Germany.

Mitsubishi Kagaku Foods Corp. manufactures and sells processed food and sugar ester. Its product includes Polysaccharide, sweetener such as Erythritol, enzyme preparations, spore forming lactic acid bacteria Lacris, natural colorants, anti-oxidants, nutrient enhancement, food additives, and antibacterial agents Wasaouro. The company was founded January 6, 1982 and is headquartered in Tokyo, Japan.